NeuroKaire vs FORE Biotherapeutics
NeuroKaire vs FORE Biotherapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: NeuroKaire is on 56/100 and FORE Biotherapeutics on 56/100.
Where each one leads
NeuroKaire
- LinkedIn following: 9,619 against 4,584
FORE Biotherapeutics
- agent readiness: 37/100 against 21/100
- domain rating: 35/100 against 8/100
- headcount: 56 against 36
- funding raised: $232M against $27.3M
At a glance
| Measure | NeuroKaire | FORE Biotherapeutics |
|---|---|---|
| What it is | Personalized medical testing tool to optimize drug therapy for depression. | Precision oncology company developing cancer therapies guided by proprietary functional genomics. |
| Category | Neuroscience, Biotech, Mental Health, Drug Therapy | Healthcare, Drug Development, Genomics, Next Generation Sequencing |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2017 | 2011 |
| Headquarters | Tel Aviv, Israel | Philadelphia, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | NeuroKaire | FORE Biotherapeutics |
|---|---|---|
| Employees | 36 | 56 |
| Headcount growthLast 12 months | Not published | +8.2% |
| Total funding | $27.3M | $232M |
| Latest round | Grant | Series D-2 Extension |
| Valuation | Not published | $75.0M |
| LinkedIn followers | 9,619 | 4,584 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | NeuroKaire | FORE Biotherapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 56/100 |
| Traction | 53/100 | 58/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 34/100 | 38/100 |
| Quality | 58/100 | 55/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 8/100 | 35/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | NeuroKaire | FORE Biotherapeutics |
|---|---|---|
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
NeuroKaire vs FORE Biotherapeutics: common questions
Which is better, NeuroKaire or FORE Biotherapeutics?
Both score the same on our 0-100 rating, so the choice comes down to the 18 data points in the tables above rather than overall company strength.
How do NeuroKaire and FORE Biotherapeutics compare on the numbers?
NeuroKaire leads on LinkedIn following (9,619 against 4,584). FORE Biotherapeutics leads on agent readiness (37/100 against 21/100), domain rating (35/100 against 8/100), headcount (56 against 36), funding raised ($232M against $27.3M).
Read the full NeuroKaire review and pricing or the FORE Biotherapeutics review and pricing. You can also browse other NeuroKaire alternatives we track.